SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,151.57 692.04
( 0.93%)

Global Indices

Nasdaq

51,732.40 -631.16
(-1.21%)

Dow Jones

7,581.68 -159.71
(-2.06%)

Hang Seng

63,112.86 -177.25
(-0.28%)

Nikkei 225

10,722.51 0.44
(0.00%)

Forex

USD-INR

95.22 0.06
(0.06%)

EUR-INR

106.19 0.24
(0.23%)

GBP-INR

127.01 0.44
(0.35%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

432.144993

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

39.04

111486.14

EPS(TTM)

Face Value()

Div & Yield %

35.35

0.94

Back

cipla ltd

Cipla consolidated net profit declines 35.05% in the September 2026 quarter

Oct 27,2026

Net profit of Cipla declined 35.05% to Rs 877.54 crore in the quarter ended September 2026 as against Rs 1351.17 crore during the previous quarter ended September 2025. Sales declined 1.06% to Rs 7368.15 crore in the quarter ended September 2026 as against Rs 7447.42 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	7368.15	7447.42	-1
OPM %	18.83	25.44	-
PBDT	1522.20	2150.52	-29
PBT	1177.34	1853.53	-36
NP	877.54	1351.17	-35

75,151.57 692.04 ( 0.93%)

51,732.40 -631.16 (-1.21%)

7,581.68 -159.71 (-2.06%)

63,112.86 -177.25 (-0.28%)

10,722.51 0.44 (0.00%)

95.22 0.06 (0.06%)

106.19 0.24 (0.23%)

127.01 0.44 (0.35%)

0.60 0.00 (0.12%)